Eden Research PLC has appointed Ilshad Moulan as the new Head of Regulatory Affairs. With a strong background in the agrochemical sector, Moulan will lead the company's regulatory strategy and execution, focusing on the global registration of its innovative crop protection solutions. His expertise in regulatory affairs management, along with a BSc degree in Biochemistry and Cell Biology and an MSc degree in Crop Protection and Regulatory Science, positions him well for this role.
Moulan's previous experience at Dr. Knoell Consult Ltd and Agrauxine, where he developed dossiers for biopesticide active ingredients and formulated plant protection products, demonstrates his capability in managing complex projects across the industry. His appointment comes at a pivotal time for Eden Research as they aim to deliver sustainable solutions to the agricultural sector and expand their global reach efficiently.
The company's CEO, Sean Smith, expressed his delight in welcoming Moulan to the team, emphasizing his extensive background in regulatory affairs and leadership skills as valuable assets. Smith also acknowledged Dr. Mike Carroll, who will retire after a handover period, for his contributions in establishing Eden's in-house regulatory capabilities and expanding regulatory authorizations for their products.
Eden Research PLC, the only UK-listed company focused on biopesticides for sustainable agriculture, develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health, and consumer products industries. Their products, formulated with terpene active ingredients, have shown promising results in improving crop yields and marketability, with equal or better performance compared to conventional pesticides.
The company's current products on the market include Mevalone®, a foliar biofungicide targeting a key disease affecting grapes and other high-value fruit and vegetable crops, Cedroz™, a bionematicide targeting free living nematodes, and Ecovelex, a seed treatment product developed to tackle crop destruction caused by birds. Additionally, Eden's Sustaine® encapsulation technology, derived from yeast, is a proven and immediately registerable solution to the microplastics problem in formulations requiring encapsulation.
Eden Research PLC, trading under the symbol EDEN on AIM, was awarded the London Stock Exchange Green Economy Mark in January 2021, further solidifying its commitment to sustainable solutions in agriculture.